Abstract
1. To study the role of cytochrome P4502C10 in the metabolism of the non-steroidal antiinflammatory drugs (NSAIDs) diclofenac, phenylbutazone, fenoprofen, ibuprofen, flurbiprofen, ketoprofen and naproxen, a cell line was developed stably expressing CYP2C10 cDNA. A retroviral vector construct, containing a human CYP2C10 cDNA, was transfected in V79-NH Chinese hamster lung cells by calcium phosphate co-precipitation. Sublines stably expressing human cytochrome P450 cDNA were established by selection with the neomycin analogue G418. 2. Enzymatic activity of CYP2C10 was detected by 4-methylhydroxylation of tolbutamide. This activity was inhibited to background levels by preincubation with the CYP2C9/10 inhibitor sulphaphenazole. 3. Preincubations with the NSAIDs ketoprofen, phenylbutazone, flurbiprofen and diclofenac (all 250 microM) caused a decrease in 4-methylhydroxylation of tolbutamide (500 microM), significantly different from control values (p < 0.05). Inhibition of this activity was not seen in preincubations with the NSAIDs fenoprofen, ibuprofen and naproxen (250 microM). 4. The V79-NH CYP2C10 cell line we have developed has been shown to be a useful tool to predict drug-drug interactions.
References
Sep 1, 1992·Trends in Pharmacological Sciences·F J Gonzalez
Jan 1, 1992·Chemical Research in Toxicology·A E RettieW F Trager
Jan 1, 1992·Life Sciences·J ZhaoP Dayer
Sep 1, 1991·Chemical Research in Toxicology·C L CrespiR Langenbach
Feb 1, 1991·Carcinogenesis·C L CrespiF J Gonzalez
Jul 31, 1990·European Journal of Biochemistry·F MorelA Guillouzo
Jan 1, 1989·Annual Review of Pharmacology and Toxicology·F P Guengerich
Jun 13, 1989·Biochemistry·W R BrianF P Guengerich
Mar 1, 1989·Trends in Pharmacological Sciences·F P Guengerich
Sep 1, 1989·Toxicology Letters·F Kiefer, F J Wiebel
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J DoehmerF Oesch
Sep 6, 1988·Biochemistry·C GedF P Guengerich
Jul 1, 1988·British Journal of Clinical Pharmacology·D J BackJ Colbert
Mar 15, 1988·Biochemical Pharmacology·J O MinersD J Birkett
May 22, 1986·Journal of Immunological Methods·F Denizot, R Lang
Apr 1, 1973·Virology·F L Graham, A J van der Eb
May 26, 1995·European Journal of Pharmacology·E M De GroeneG J Horbach
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
May 11, 1995·Biochemical Pharmacology·T S TracyK R Korzekwa
Jan 1, 1993·Life Sciences·T LeemannP Dayer
Citations
Dec 1, 1998·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M MonshouwerA S van Miert
Mar 23, 2000·Mutation Research·W A KappersG J Horbach
May 23, 1998·Journal of Veterinary Pharmacology and Therapeutics·W M Zweers-ZeilmakerR F Witkamp
Feb 1, 1997·Drug Metabolism Reviews·S Rendic, F J Di Carlo
Dec 14, 1999·British Journal of Clinical Pharmacology·P DamkierK Brosen